A New Antioxidant with Alkyl Hydroperoxide Defense Properties in Yeast*

Jaekwon LeeDagger , Daniel SpectorDagger §, Christian Godon§, Jean Labarre§, and Michel B. ToledanoDagger §

From the Dagger  Department of Pharmacology and Toxicology, College of Pharmacy, Rutgers University, Piscataway, New Jersey 08855 and § Service de Biochimie et Génétique Moléculaire, Bât 142, CEA-Saclay, F-91191 Gif-sur-Yvette Cedex, France

    ABSTRACT
Top
Abstract
Introduction
References

To isolate new antioxidant genes, we have searched for activities that would rescue the tert-butyl hydroperoxide (t-BOOH)-hypersensitive phenotype of a Saccharomyces cerevisiae strain deleted for the gene encoding the oxidative stress response regulator Skn7. We report the characterization of AHP1, which encodes a 19-kDa protein similar to the AhpC/TSA protein family within a small region encompassing Cys-62 of Ahp1p and the highly conserved N-terminal catalytic AhpC/TSA cysteine. Ahp1p contains a peroxisomal sorting signal, suggesting a peroxisomal localization. AHP1 exerts strong antioxidant protective functions, as demonstrated both by gene overexpression and deletion analyses, and is inducible by peroxides in an Yap1- and Skn7-dependent manner. Similar to yeast Tsa1p, Ahp1p forms a disulfide-linked homodimer upon oxidation and in vivo requires the presence of the thioredoxin system but not of glutathione to perform its antioxidant protective function. Furthermore, in contrast to Tsa1p, which is specific for H2O2, Ahp1p is specific for organic peroxides. Therefore, with respect to substrate specificity, Ahp1p differs from Tsa1p and is similar to prokaryotic alkyl hydroperoxide reductase AhpC. These data suggest that Ahp1p is a yeast orthologue of prokaryotic AhpC and justifies its name of yeast alkyl hydroperoxide reductase.

    INTRODUCTION
Top
Abstract
Introduction
References

The incomplete reduction of molecular oxygen during respiration and the lipid metabolism in peroxisomes leads to the formation of reactive oxygen species (ROS)1 (1). ROS are potent oxidants and can damage all cellular constituents (2). They cause DNA base modifications and strand breaks and are therefore mutagenic. They can damage proteins and inactivate enzymes. Oxidation of membrane lipids can initiate free radical chain reactions, which alter cellular membranes and give rise to other very toxic reactive species such as lipid hydroperoxides, alkoxyl and peroxyl radicals, lipid epoxides, and aldehydes. To protect against the toxicity of ROS, aerobic organisms use an array of defense mechanisms (1, 3, 4). Among these, cytosolic and mitochondrial superoxide dismutases eliminate the Obardot 2 radical, cytosolic and peroxisomal catalases remove H2O2, and glutathione peroxidases reduce both H2O2 and alkyl hydroperoxides. The AhpC/TSA family, also referred to as peroxiredoxin, is a large family of newly discovered peroxidases that are highly conserved from prokaryotes to eukaryotes (5) and act to reduce hydroperoxides with electrons donated by NADPH via thioredoxin or other thiol-containing intermediates (6-8). Antioxidant defense mechanisms are induced as part of global cellular adaptive responses to oxidative stress (9-12). In Saccharomyces cerevisiae, the cellular response to hydroperoxides is associated with the induction of a very large stimulon of at least 115 proteins (13), which involves, at least in part, the transcriptional regulators Yap1 (14, 15) and Skn7 (16, 17). Strains inactivated for either one of these regulators are hypersensitive to killing by H2O2 and by several other oxidants (15, 16, 18). Yap1 controls the expression of GSH1-encoded gamma -glutamylcysteine synthetase (19) and of GLR1-encoded glutathione reductase (20) and co-operates with Skn7 to activate the expression of TRX2-encoded thioredoxin and TRR1-encoded thioredoxin reductase (17).

To gain insight into the molecular physiology of the yeast oxidative stress response, we have attempted to identify new genes involved in the cellular defense against alkyl hydroperoxides and possible targets of Yap1 and Skn7. As an approach to this question, we have used a genetic selection for identifying genes, which could rescue the alkyl hydroperoxide hypersensivity of an skn7 null strain. We report the identification of one of the genes isolated from this selection, which we have named AHP1 (see below). Evidence is provided which demonstrates that the AHP1 gene product is a yeast antioxidant related to the AhpC/TSA peroxiredoxin family with alkyl hydroperoxide defense properties.

    MATERIALS AND METHODS

Yeast Strains and Growth Conditions

Studies were performed with the wild type strain YPH98 (21) as indicated in the legends (MATa ura3-52 lys2-801amber ade2-101ochre trp1-Delta 1 leu2-Delta 1) and its isogenic derivatives yMT1 (yap1::LEU2), yMT2 (skn7::TRP1), yMT3 (yap1::LEU2, skn7::TRP1), yMT4 (gsh1::LEU2), yMT5 (ahp1::TRP1), yMT6 (tsa1::TRP1), and yMT7 (trr1::TRP1). The following strains were also used as indicated in the legends and are derived from W303: wild type strain EMY60 (MATa, ade3, ade2 trp1-1, leu2-3, 112, ura3-1, his3-11, can1-100), EMY61 (trx1::TRP1), EMY62 (trx2::LEU2), and EMY63 (trx1::TRP1, trx2::LEU2) and are a gifts from Dr. E. G. Muller (University of Washington, Seattle, WA) (22, 23). The composition of synthetic complete medium (SC), rich broth medium (YPD), glucose (SMG), and galactose selective media (SMGal) are described elsewhere (24). Strains were transformed by electroporation as described (25).

Gene Disruptions and Plasmid Constructions

Standard protocols and buffers were used (26). Gene disruptions were performed by the one-step gene disruption technique (25). The skn7::TRP1 construct used to create yMT2 was a gift from Dr. H. Bussey (McGill University, Montreal, Canada) (27). The yap1::LEU2 construct used to create yMT1 was prepared by removing the YAP1 coding sequence from the BamHI site (+186) to the KpnI site (+1650) relative to the ATG and replacing it with the LEU2 gene. The ahp1::TRP1 deletion construct used to generate yMT5 was prepared by replacing the full AHP1 open reading frame (ORF) with the TRP1 gene. Basically, oligonucleotide primers were used to PCR-amplify 5' (-680 to +5) and 3' (+532 to +1530) regions of the AHP1 gene relative to the ATG. These PCR-amplified fragments were then subcloned upstream and downstream of the TRP1 gene. The deletion construct used to create yMT4 (gsh1::LEU2) was prepared by removing a 700-base pair DNA fragment from the HindIII site at -180 base pairs relative to the ATG up to the BamHI site at +511 and replacing it with the LEU2 gene. yMT6 and yMT7 were prepared by a one-step amplification protocol that replaced the entire TSA1 or TRR1 ORF with the TRP1 gene (28). The cDNA library plasmid pY1 contained the entire AHP1 ORF from -119 relative to the translation start to +614, 82 base pairs downstream of the stop codon. To generate pAHP1, the AHP1 gene was isolated by PCR amplification of total yeast DNA with oligonucleotides that primed from -984 to +614, and then cloned into the polylinker region of plasmid pRS426 between the BamHI and NotI sites.

Selection of Yeast cDNAs

A S. cerevisiae cDNA library under control of the repressible GAL1 promoter in the centromeric vector pRS316 (29) was transformed into strain yMT2 (skn7::TRP1). Transformed cells were plated onto SMG lacking uracil and containing 1 M sorbitol. URA3 transformants were pooled from each plate separately, diluted, and then plated onto SMGal lacking uracil and containing t-BOOH (0.5 mM). Plates were incubated at 30 °C for 5-12 days. Plasmids recovered from viable colonies were analyzed by restriction digest and sequencing. Sequencing was performed using an automated Perkin-Elmer DNA sequencer according to the recommendations of the manufacturer.

Sensitivity Assays

Patch Assays-- Aliquots (10 µl) containing approximately 103 or the indicated cell number of an overnight culture were spotted on YPD plates containing oxidants at the indicated concentration. Plates were monitored after 3-6 days of incubation at 30 °C.

Challenge Assay-- Cells from an exponential growth culture were washed, resuspended in phosphate-buffered saline at a density of OD600 of 0.1, and not exposed or exposed to peroxides at different concentrations for 1 h. Cells were then diluted and plated for colony survival.

Northern Blot Analysis

Yeast cells from overnight culture were diluted to an OD600 of 0.01 in SC medium and incubated with shaking at 30 °C until they reached an OD of 0.3. The cells were then aliquoted and incubated in the absence or in the presence of H2O2 (0.2 mM) or t-BOOH (0.2 mM) for 20 min. Total RNA was prepared by the hot phenol method (30). For each condition tested, 20-µg RNA samples were loaded per lane on an agarose gel containing formaldehyde, separated by electrophoresis, transferred to a Bio-Rad nylon membrane, and hybridized with an an AHP1 32P-labeled DNA specific probe produced by random priming (Boehringer Mannheim). Hybridization of each blot with a small nuclear RNA U3 (SNR17A)-specific 32P-labeled DNA probe served as a RNA loading control. Prehybridization, hybridization, and washes were carried out as described elsewhere (26). Hybridized membrane were exposed for autoradiography.

Two-dimensional Gel Electrophoresis and Protein Spot Identification

Two-dimensional gel electrophoresis and protein spot identification were performed as described elsewhere (13). Alkylation of protein free sulfhydryls before the second dimension was achieved as follows. The first dimensional gel rod was first reduced by a 10-min incubation in buffer A (30% glycerol, 6 M urea, 2.5% SDS, 0.001% bromphenol blue, 0.2 M Bis-Tris, 0.1 M HCl, and 67 mM dithiothreitol (DTT)). Alkylation was then performed by incubating the gel rod in buffer in which DTT was omitted, and iodoacetamide (222 mM) was added instead.

    RESULTS

Selection of Genes Increasing the Tolerance to t-BOOH of a skn7 Null Strain-- A S. cerevisiae strain carrying a skn7 null mutation fails to grow on medium containing 0.5 mM of t-BOOH (a synthetic alkyl hydroperoxide), whereas the isogenic wild type strain will tolerate up to 1.5 mM of this oxidant. We have searched for genes whose overexpression would rescue the t-BOOH hypersensitivity of the skn7 null strain using a galactose-inducible yeast cDNA library (29). This library was used to bypass the possible Skn7 requirement for the expression of candidate genes. We expected to identify genes controlled by Skn7 and/or encoding alkyl hydroperoxide antioxidant defense activities. Strain yMT2 (skn7::TRP1) was transformed with the GAL1-controlled cDNA library. Forty thousand transformants were obtained and incubated on plates containing 0.5 mM t-BOOH. Viable colonies were recovered from these plates after 7 days and the corresponding library plasmids isolated. Five plasmids, able to increase the t-BOOH tolerance of the yMT2 strain upon retransformation, were shown to carry inserts of different sizes, but containing the same ORF. One of them, pY1, was further analyzed. pY1 was able to increase the tolerance to t-BOOH not only of yMT2 but also of yMT1 (a yap1 null strain) (Fig. 1). Therefore, the gene carried on the pY1 plasmid has antioxidant properties. This gene was called AHP1 for alkyl hydroperoxide reductase (see below) and further analyzed. The AHP1 gene is encoded at the YLR109W locus. Interestingly, its gene product has been recently identified as a 19-kDa protein by comparative two-dimensional gel electrophoresis in the search of yeast proteins induced by H2O2 (13).


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 1.   The AHP1 gene partially rescues the t-BOOH-hypersensitive phenotype of skn7 and yap1 null strains. skn7 and yap1 null strains not carrying (Delta skn7, Delta yap1) or carrying the pY1 plasmid (Delta skn7pGAL1AHP1, Delta yap1pGAL1AHP1), which expresses the AHP1 gene under control of the GAL1 promoter and isogenic wild type strain, were compared by the patch assay for their ability to grow on SDGal solid medium containing t-BOOH at the indicated concentration. For each strain, 10 µl of an overnight culture (OD600 2-3) diluted to 20, 5, or 1 × 103 cells (from left to right) were spotted on tester plates.

Similarity of Ahp1p with Peroxisomal-like Proteins and with the AhpC/TSA Protein Family-- Ahp1p is a protein predicted to be 176 amino acids long with a molecular mass of 19,108 Da (Fig. 2). This predicted mass is in agreement with a molecular weight of 19,000 extrapolated from its mobility in denaturing polyacrylamide gels (13) (see also Fig. 6). Ahp1p contains 3 cysteine residues at positions 31 (Cys-31), 62 (Cys-62), and 120 (Cys-120). Ahp1p carries the C-terminal sequence AHL similar to the putative S(A)K(H/R)L(I) peroxisomal-like sorting signal sequence (31). A sequence comparison with the GenBank data base revealed that Ahp1p is highly similar throughout its entire sequence to five peroxisomal-like fungal proteins, and to three other prokaryotic proteins. Ahp1p has also a weak, yet significant similarity to the peroxiredoxin AhpC/TSA family.


View larger version (53K):
[in this window]
[in a new window]
 
Fig. 2.   Nucleotide sequence of the AHP1 gene and the predicted amino acid sequence of the Ahp1 protein. The nucleotide sequence of the AHP1 gene and its flanking regions is shown in the 5' to 3' direction. The predicted amino acid sequence of Ahp1p is indicated below the relevant nucleotides. The Yap1 response element (TTAGTAA) and the three putative stress response elements (CCCCT) are indicated in boldface and underlined. The two TATA boxes are also indicated. The three cysteines and the AHL peroxisomal-like sorting signal of Ahp1p are indicated in boldface.

The sequences of the proteins that are highly similar to Ahp1p are compared in Fig. 3. Of the three Ahp1p cysteines, Cys-62 is the only one conserved among these related proteins and occupies a region with a high density of amino acid identities. Cys-31 is conserved only in Lipomyces kononenkoae peroxisomal-like protein and in Aspergillus fumigatus Aspf3 protein. C. bondinii PMP20 A and B proteins (32) and the other related fungal protein sequences all contain a tripeptide peroxisomal-like sorting signal at their extreme C terminus. Inspection of these related sequences also shows that the Haemophilus influenzae Y572 protein has an additional C-terminal domain with a very strong similarity to the redox-active center of glutaredoxins (Fig. 3). C. bondinii PMP20 A and B are two isoforms of a protein that was identified as the most abundant peroxisomal proteins of methanol-exposed cells but was not assigned any specific function (32, 33). None of the other proteins shown in Fig. 3 have an identified function. Nevertheless, the presence of a glutaredoxin-like domain in Y572 suggests that this protein might be involved in redox reactions.


View larger version (83K):
[in this window]
[in a new window]
 
Fig. 3.   Sequence similarity between Ahp1p, a family of peroxisomal membrane proteins, and the peroxiredoxin AhpC/TSA family. Amino acid sequence alignment of Ahp1p with its fungi and prokaryotic structural homologues. The alignment was performed using the BLAST 2.0 at the National Center for Biotechnology Information (47). Identical amino acids are boxed. Abbreviations and percent of overall identity and similarity (in parentheses): L.k. PLP, putative 17.3-kDa L. kononenkoae peroxisomal-like protein (40%, 57%) (48); PMP20 A, C. bondinii peroxisomal membrane protein A (39%, 56%); A.f. Aspf3, A. fumigatus 18.5-kDa peroxisomal-like protein (36%, 53%) (49); S.p. PMP20, Schizosaccharomyces pombe PMP20 homologue (29%, 50%) (EMBL accession no. SPAJ2536); Y572, hypothetical H. influenzae 26.7-kDa protein (34%, 55%)(Swiss-Prot accession P44758); R.e. rpoN2, Rhizobium etli hypothetical protein (29%, 50%) (EMBL accession no. RET5696); S.sp. MP, Synechocystis sp. hypothetical membrane protein (27%, 46%) (DDBJ accession no. D90909).

The overall similarity between Ahp1p and the AhpC/TSA family is confined in a very short sequence surrounding Ahp1p Cys-62 and the highly conserved N-terminal catalytic cysteine of the AhpC/TSA homology (5, 7). This similarity between Ahp1p and the AhpC/TSA family is shared among all the Ahp1p homologues shown in Fig. 3. The functional importance of the N-terminal cysteine in the peroxidase function of Tsa1p (7, 34) strongly suggests that Ahp1p and its homologues may have an equivalent function. We therefore analyzed in detail the in vivo antioxidant properties of Ahp1p.

Ahp1p Is an Antioxidant Specific for Organic Peroxides-- A null mutation of the AHP1 gene that removes all its coding sequence was created. The viability of the resulting ahp1 null strain demonstrates that this gene is not essential. The ahp1 null strain does not have any particular growth phenotype on glucose, galactose, acetate, pyruvate, or oleate media or under anaerobic conditions. The effect of the ahp1 null mutation was then tested on the stress tolerance to t-BOOH by a patch assay. Compared with its isogenic wild type control, the ahp1 null strain is hypersensitive to t-BOOH (Fig. 4A). Conversely, high expression of AHP1 from a multicopy plasmid dramatically increases the resistance of the wild type strain toward t-BOOH (Fig. 4C). Note that the difference in t-BOOH sensitivity of wild type cells in panels A and C is related to the different strain backgrounds used in these experiments (see figure legend and "Experimental Procedures"). The role of AHP1 in the stress tolerance to H2O2 was then examined. In sharp contrast to its role in t-BOOH tolerance, the ahp1 null mutation barely affects the cell tolerance to H2O2 (Fig. 4B) and high expression of AHP1 does not improve the wild type strain tolerance to H2O2 (Fig. 4C). Similar results were obtained by a challenge assay (data not shown). These results suggested that AHP1 is involved in the cellular defense against t-BOOH but not against H2O2. This prompted us to compare the antioxidant properties of Ahp1p with those of the structurally related Tsa1p/peroxiredoxin. An in vitro measurement of Tsa1p catalytic activity had shown that this enzyme is more efficient in reducing H2O2 than t-BOOH (7). Significantly, the tsa1 null mutant is hypersensitive to killing by H2O2 and has a wild type resistance to t-BOOH (Fig. 4, A and B).


View larger version (36K):
[in this window]
[in a new window]
 
Fig. 4.   Antioxidant and metal protective properties of Ahp1p. A and B, ahp1 null (Delta ahp1), tsa1 null (Delta tsa1), and isogenic wild type strains (WT) in the YPH98 background were compared for their ability to grow on YPD not containing any added chemical or containing either t-BOOH (A) or H2O2 (B) at the indicated concentrations. C, a wild type strain (EMY60) not carrying (-) or carrying (+) an episomal plasmid expressing AHP1 under control of its own promoter (pAHP1) were tested for resistance to t-BOOH or to H2O2 at the indicated concentrations. D, an ahp1 null (Delta ahp1) and isogenic wild type strain (WT) (YPH98) not carrying or carrying an episomal plasmid expressing AHP1 under control of its own promoter (pAHP1) were compared for their ability to grow on YPD containing diamide (1.4 mM), menadione (0.1 mM), or cadmium (0.1 mM). For each strain, 10 µl of an overnight culture (OD600 2-3) diluted to 20, 5, or 1 × 103 cells (from left to right) were spotted on tester plates. Growth was monitored after 3 days for all plates except for cadmium plates and after 6 days for cadmium plates.

The antioxidant properties of AHP1 were also tested toward several other oxidants and a metal (Fig. 4D). The ahp1 null mutation results in a slight decrease in the tolerance to the thioloxidant diamide and to cadmium and suprisingly to an increase in the resistance to the superoxide generating redox cycling drug menadione. However, high copy expression of AHP1 has no effect on the wild type strain tolerance to any of these compounds.

The Antioxidant Function of Ahp1p Is Independent of GSH and Dependent upon the Thioredoxin System-- Tsa1p1 reduces peroxides with electrons donated by thioredoxin, thioredoxin reductase, and NADPH (7, 34), whereas AhpC reduces organic peroxides with electrons donated by the FAD-bound NADPH-dependent AhpF reductase (6). We thus sought to determine the potential requirement of an electron donor system for the Ahp1p antioxidant function. The effect of overexpressing AHP1 on t-BOOH resistance was tested in strains deleted of thioredoxin 1 (TRX1), thioredoxin 2 (TRX2), or both TRX1 and TRX2 (Fig. 5A). The trx1 null strain has a normal tolerance toward t-BOOH, whereas the trx2 null mutant is slightly more sensitive than the wild type strain to this oxidant (15) (compare Fig. 5A with Fig. 4C). However, the trx1trx2 double null strain is hypersensitive to t-BOOH. In the trx1 null strain, overexpression of AHP1 results in a significant increase in the resistance to t-BOOH, similar to that seen in the wild type strain (compare Fig. 5A and 4C). In the trx2 null strain, the effect of overexpressing AHP1 can be seen only at the lower t-BOOH concentrations. In the trx1trx2 null strain, no effect can be seen upon overexpression of AHP1. A thioredoxin reductase (TRR1) deletion mutant also displayed a t-BOOH-hypersensitive phenotype that was not improved by overexpression of AHP1 (data not shown).


View larger version (47K):
[in this window]
[in a new window]
 
Fig. 5.   The antioxidant function of Ahp1p is independent of GSH but dependent upon the thioredoxin system. Patch assays monitoring the sensitivity of genetically modified strains to peroxides. A, isogenic strains, derived from EMY60, with null deletions of TRX1 (Delta trx1), TRX2 (Delta trx2), or both TRX1 and TRX2 (Delta trx1Delta trx2), not carrying (-) or carrying (+) an episomal plasmid expressing AHP1 from its own promoter (pAHP1) were tested on YPD solid media containing t-BOOH at the indicated concentrations. B, a wild type (WT) in the YPH98 background and isogenic strain with a GSH1 null deletion (Delta gsh1) not carrying or carrying an episomal plasmid expressing AHP1 from its own promoter (pAHP1) were tested on YPD medium containing t-BOOH at the indicated concentrations.

The effect of overexpressing AHP1 on t-BOOH resistance was also tested in strains deleted for gamma -glutamylcysteine synthase (GSH1), the rate-limiting enzyme in glutathione (GSH) biosynthesis (Fig. 5B). The gsh1 null strain appears slightly more resistant to t-BOOH than the wild type strain, suggesting that high levels of GSH are not required for the resistance to this oxidant (the gsh1 null strain is auxotroph for GSH and can only grow in the presence of at least minimal amounts of exogenous GSH supplement such as those present in YPD-rich medium; Ref. 35). In addition, the gsh1 null mutation does not affect the gain in t-BOOH resistance resulting from AHP1 overexpression. Taken together, these data show that thioredoxins but not GSH are important in the protection against t-BOOH and provide indirect evidence for the requirement of the thioredoxin system, but not of GSH, in the antioxidant protective function of Ahp1p.

Ahp1p Can Form a Disulfide-linked Homodimer in Vitro-- Ahp1p was identified on two-dimensional gel electrophoresis of total yeast proteins as a H2O2-inducible spot migrating at a pI of 4.5 and a molecular weight of 19,000. Interestingly, an unidentified H2O2-induced spot with a pI identical to that of Ahp1p and a molecular weight of 40,000 was observed (Fig. 6). We suspected that this unknown spot could represent a dimeric form or other covalent modifications of Ahp1p. This spot was indeed identified as Ahp1p by peptide mapping using matrix-assisted laser desorption ionization-time of flight/mass spectrometry (36). We next asked whether the 40-kDa spot could represent a disulfide-linked dimer of Ahp1p. Cellular extracts subjected to two-dimensional gel electrophoresis are initially reduced in a buffer containing 160 mM beta -mercaptoethanol. However, some substrates could be potentially reoxidized during the second dimension, when all of the beta -mercaptoethanol has been lost during electrophoresis. To test this hypothesis, the first dimension polyacrylamide rod was incubated in a buffer containing DTT to reduce any potentially reoxidized cysteine residues, and then treated in a buffer containing the cysteine alkylating agent iodoacetamide, which irreversibly blocks free sulfhydryls. As shown in Fig. 6, this procedure led to the complete disappearance of the 40-kDa spot. These data strongly suggest that the 40-kDa Ahp1p spot represents a disulfide-linked Ahp1p homodimer.


View larger version (120K):
[in this window]
[in a new window]
 
Fig. 6.   Ahp1p can form a disulfide-linked homodimer in vitro. Autoradiogram of two-dimensional gel electrophoresis performed with total cellular extracts from [5S]methionine-labeled exponentially growing wild type YPH98 cells. The 19-kDa Ahp1p protein and the 40-kDa Ahp1p dimer identified by mass spectrometry are indicated by an arrow. A, extracts prepared from untreated cells. B, extracts prepared from cells exposed to H2O2 (0.4 mM) for 15 min. C, alkylated extracts prepared from untreated cells. In this case, the two-dimensional gel electrophoresis procedure was modified by the following change; after the first-dimensional electrophoresis, the resulting polyacrylamide rod was incubated in a buffer containing DTT and then treated with iodoacetamide before subjecting it to the second electrophoretic dimension.

AHP1 Is Regulated by Yap1 and Skn7-- Ahp1p is an abundant protein under non induced conditions, and its synthesis rate is increased by about 3-fold upon exposure to H2O2 (13). We therefore analyzed whether the peroxide stimulation of Ahp1p was dependent upon Yap1 and Skn7. Northern blots were performed using an AHP1 specific probe and total RNA from exponentially growing wild type, yap1, and skn7 null cells that had not been treated or were treated with 0.2 mM amounts of either t-BOOH or H2O2. In wild type cells, AHP1 mRNA levels were significantly increased upon H2O2 (Fig. 7A) or t-BOOH (Fig. 7B) exposure, confirming the results of the two-dimensional gel analysis. In contrast, in yap1 or in skn7 null strains, both uninduced and t-BOOH-induced AHP1 mRNA levels were significantly decreased, although they could still be moderately induced by peroxide. However, this residual induction was not seen in the yap1skn7 double null strain, although some uninduced levels persisted (Fig. 7C). Consistent with a transcriptional control by Yap1, the 5' AHP1 flank contains the sequence TTAGTAA at position (-484) from the start codon, which perfectly matches a Yap1 response element (Fig. 1) (37).


View larger version (43K):
[in this window]
[in a new window]
 
Fig. 7.   AHP1 is an oxidative stress-inducible gene regulated by Yap1 and Skn7. Northern blot analysis of AHP1 transcription. A, total RNA was isolated from exponentially growing (OD600 0.3) wild type cells (WT), and isogenic strains with null deletion of YAP1 (Delta yap1), SKN7 (Delta skn7), which had not been treated or were treated for 20 min with H2O2 (0.2 mM) as indicated. The resulting RNA were subjected to Northern blot which was probed for AHP1 and U3 as a loading control, as described under "Experimental Procedures." B, same as in A, but cells were induced by t-BOOH (0.2 mM) instead of H2O2. C,total RNA was isolated from wild type (lane 1 to 3) and from an isogenic strain with a null deletion of Yap1 and Skn7 (Delta yap1Delta skn7). Cells were not treated (lanes 1 and 4) or were treated for 20 min by H2O2 (0.2 mM) (lanes 2 and 5) or by t-BOOH (0.2 mM) (lanes 3 and 6). Densitometric quantification of the autoradiogram normalized to the U3 loading control; relative values are given for each lane: 1 (2.83), 2 (8.16), 3 (6.37), 4 (0), 5 (1.68), and 6 (1.77).


    DISCUSSION

Oxidative damage to lipids can lead to a variety of alkyl hydroperoxides, which are particularly detrimental due to their ability to initiate and propagate free radical chain reactions. Enzymes involved in the breakdown of alkyl hydroperoxides are thus important for protection against oxidative stress. We report here the characterization of AHP1, which encodes a yeast antioxidant important for the protection against alkyl hydroperoxides, and related to the AhpC/TSA peroxiredoxin family.

Gene deletion and overexpression analyses have demonstrated that AHP1 exerts strong antioxidant protective functions. Furthermore, the observation that AHP1 mRNA and protein levels are induced by peroxides in a Yap1- and Skn7-dependent manner also supports the notion that Ahp1p is involved in protecting yeast cells from oxidative stress. Therefore, AHP1 can be added to the growing list of yeast antioxidant genes of the Yap1 and Skn7 regulons, which includes TRX2-encoded thioredoxin (15), GSH1-encoded gamma -glutamylcysteine synthetase (19), GLR1-encoded glutathione reductase (20), and TRR1-encoded thioredoxin reductase (17).

Sequence analysis relates this antioxidant to the AhpC/TSA protein family. Although mostly confined to a small region surrounding Cys62 of Ahp1p and the highly conserved N-terminal cysteine of the AhpC/TSA proteins family (5), this homology is functionally important because the N-terminal cysteine of yeast Tsa1p is the catalytic center of its peroxidase function (7, 34). The proposed catalytic mechanism for Tsa1p involves substrate peroxide reduction by Cys N terminus, which upon oxidation reacts with the Cys C terminus of another subunit to form an intermolecular disulfide. This disulfide is subsequently reduced with electrons donated by thioredoxin, thioredoxin reductase, and NADPH (7, 34). It was observed that Ahp1p forms a disulfide-linked homodimer upon oxidation. Furthermore, genetic data suggested that the antioxidant protective function of AHP1 is independent of GSH but dependent upon both thioredoxin and thioredoxin reductase. Therefore, the structural similarity between Ahp1p and Tsa1p may be extended to a common mode of action, which suggests that a peroxidase function underlies the antioxidant properties of Ahp1p. Of the three Ahp1p cysteines, Cys-62 would be most likely to be involved in direct substrate peroxide reduction. However, it is not clear whether another cysteine would play a role in the putative Ahp1p catalytic function, nor which cysteine(s) is (are) involved in homodimer disulfide bond formation. Site-directed mutagenesis of individual cysteines of Ahp1p will answer these questions.

The antioxidant protective function of AHP1 appears specific for organic peroxides. The slight increase in H2O2 sensitivity, and perhaps the altered diamide tolerance phenotype seen in the ahp1 null mutant, could be related to the lipid hydroperoxides which might be generated upon exposure to these oxidants. Although not an oxidant, cadmium may also lead to the production of ROS through metal-catalyzed electron transfer (38, 39), and its toxicity might therefore be exacerbated by the lack of AHP1. It is unlikely that cadmium is a direct substrate for Ahp1p. The menadione hyperresistance phenotype of the ahp1 null strain is not understood but could be related to a deregulated expression of superoxide defense genes. Interestingly, an in vivo comparison of the substrate specificities of Ahp1p and Tsa1p showed that, whereas Ahp1p activity is specific for organic peroxides, Tsa1p activity is specific for H2O2. This observed in vivo substrate specificity of Tsa1p is fully consistent with in vitro measurements of its catalytic activity toward t-BOOH and H2O2 (7). Therefore, with respect to its substrate specificity, Ahp1p differs from Tsa1p and appears related to the Escherichia coli and Salmonella typhimurium alkyl hydroperoxide reductase AhpC, which is specifically involved in the breakdown of lipid and other alkyl hydroperoxides, but not of H2O2 (6).

Eukaryotic cells have several enzymes involved in the breakdown of lipid hydroperoxides. The structurally related selenoproteins glutathione peroxidase (40) and phospholipid hydroperoxide glutathione peroxidase (41, 42) can reduce both alkyl hydroperoxides and H2O2. However, glutathione peroxidase is more active toward H2O2, whereas phospholipid hydroperoxide glutathione peroxidase is more specific for lipid hydroperoxides (41, 43). Furthermore, only phospholipid hydroperoxide glutathione peroxidase can catalyze the reduction of lipid hydroperoxide derivatives of intact phospholipids. Glutathione S-transferase isozymes are also able to reduce lipid hydroperoxides with GSH (44, 45). Another pathway for the reduction of lipid hydroperoxides is constituted by NADPH-dependent thioredoxin reductase (46). However, an eukaryotic orthologue of prokaryotic AhpC has not been described. We suggest, based on substrate specificity and structural homology, that Ahp1p is a peroxidase and the yeast orthologue of prokaryotic AhpC.

Ahp1p is highly similar to C. bondinii PMP20 A and B and to several other fungi and prokaryotic proteins (see Fig. 1B). C. bondinii PMP20 A and B are two isoforms of a protein identified as the most abundant peroxisomal protein of methanol-exposed cells and suspected to play a role in methanol metabolism (32, 33). However, these two proteins and their fungi and prokaryotic homologues (see Fig. 3A), which share with Ahp1p the same similarity to the AhpC/TSA family, may have also a peroxidase function. Consistent with this idea is the presence of a C-terminal glutaredoxin domain in the H. influenzae Y572, which may serve as an electron donor for the catalytic cysteine of this putative peroxidase. Based on immunostaining and cellular subfractionation experiments, PMP20 is a peroxisomal protein tightly associated with membranes (33). Consistent with this localization, PMP20 A and B contain a C-terminal peroxisomal sorting signal sequence (32). A similar peroxisomal sorting signal is present in Ahp1p and in the other PMP20-related fungi proteins, suggesting that they may all be similarly localized in peroxisomes. However, the abundance of Ahp1p observed on two-dimensional gels, which only analyze soluble proteins, and its presence in high quantity in the supernatant of a stationary cell culture (data not shown), may indicate that this polypeptide is also present in the cytosol and is shed out of the cell in the medium. A detailed analysis of Ahp1p subcellular location will provide an answer to this question.

In summary, AHP1 encodes an AhpC/TSA-related antioxidant with apparent substrate specificity for alkyl hydroperoxides. These data suggest that this antioxidant is a yeast orthologue of prokaryotic AhpC and justifies its name of Ahp1p for yeast alkyl hydroperoxide reductase. AHP1 is coordinately controlled with TRX2 and TRR1 by Yap1 and Skn7 and requires the presence of these two enzymes to exert in vivo its antioxidant protective function. In vitro measurements of the antioxidant activity of wild type and Ahp1p cysteine substitution mutants will provide a detailed analysis of its peroxidase function and will confirm the role of the thioredoxin system in supporting the antioxidant activity of Ahp1p. Further studies aimed at analyzing the redox characteristics of Ahp1p and understanding the molecular basis of its substrate specificity will be of interest. In that respect, the propensity of Ahp1p to oxidize to a disulfide-linked homodimer during electrophoresis is quite striking and suggests a high reactivity to oxidation in vitro and probably also in vivo of one or more of its cysteines.

    ACKNOWLEDGEMENTS

We thank Howard Bussey, Steve Moye-Rowley, and Eric Muller for their generous gifts and Kiran Madura for the yeast cDNA library. We also thank Jerome Garin for the identification of the Ahp1p dimer on two-dimensional gels, Gilles Lagniel for technical assistance, and André Sentenac and Raquel Levy-Toledano for critical review of the manuscript.

    FOOTNOTES

* This work was supported a grant from the New Jersey Commission for Cancer Research (to M. B. T.) and by a National Institutes of Health predoctoral fellowship (to D. S.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) Z73281.

To whom correspondence should be addressed: Service de Biochimie et Génétique Moléculaire, Bât 142, CEA-Saclay, F-91191 Gif-sur-Yvette Cedex, France. Tel.: 33-1-69-08-82-44; Fax: 33-1-69-08-47-12; E-mail: toledano{at}jonas.saclay.cea.fr.

    ABBREVIATIONS

The abbreviations used are: ROS, reactive oxygen species; PCR, polymerase chain reaction; DTT, dithiothreitol; ORF, open reading frame; t-BOOH, tert-butyl hydroperoxide.

    REFERENCES
Top
Abstract
Introduction
References
  1. Halliwell, B., and Gutteridge, J. M. C. (1989) Free Radicals in Biology and Medicine, Clarendon Press, Oxford
  2. Sies, H. (1986) Angew. Chem. Int. Ed. Engl. 25, 1058-1071[CrossRef]
  3. Fridovich, I. (1978) Science 201, 875-880[Medline] [Order article via Infotrieve]
  4. Sies, H. (1993) Eur. J. Biochem. 215, 213-219[Abstract]
  5. Chae, H. Z., and Rhee, S. G. (1994) Biofactors 4, 177-180[Medline] [Order article via Infotrieve]
  6. Jacobson, F. S., Morgan, R. W., Christman, M. F., and Ames, B. N. (1989) J. Biol. Chem. 264, 1488-1496[Abstract/Free Full Text]
  7. Chae, H. Z., Chung, S. J., and Rhee, S. G. (1994) J. Biol. Chem. 269, 27670-27678[Abstract/Free Full Text]
  8. Kwon, S. J., Park, J.-W., Choi, W.-K., Kim, I. H., and Kim, K. (1994) Biochem. Biophys. Res. Commun. 201, 8-15[CrossRef][Medline] [Order article via Infotrieve]
  9. Storz, G., Tartaglia, L. A., Farr, S. B., and Ames, B. N. (1990) Trends Genet. 6, 363-368[CrossRef][Medline] [Order article via Infotrieve]
  10. Demple, B. (1991) Annu. Rev. Genet. 25, 315-335[CrossRef][Medline] [Order article via Infotrieve]
  11. Demple, B., and Amabile-Cuevas, C. F. (1991) Cell 67, 837-839[Medline] [Order article via Infotrieve]
  12. Crawford, D. R., and Davis, K. J. A. (1994) Environ. Health Perspect. 102, 25-28[Medline] [Order article via Infotrieve]
  13. Godon, C., Lagniel, G., Lee, J., Buhler, J.-M., Kieffer, S., Perrot, M., Boucherie, H., Toledano, M. B., and Labarre, J. (1998) J. Biol. Chem. 273, 22480-22489[Abstract/Free Full Text]
  14. Schnell, N., Krems, B., and Entian, K.-D. (1992) Curr. Genet. 21, 269-273[Medline] [Order article via Infotrieve]
  15. Kuge, S., and Jones, N. (1994) EMBO J. 13, 655-664[Abstract]
  16. Krems, B., Charizanis, C., and Entian, K.-D. (1996) Curr. Genet. 29, 327-334[CrossRef][Medline] [Order article via Infotrieve]
  17. Morgan, B. A., Banks, G. R., Toone, W. M., Raitt, D., Kuge, S., and Johnston, L. H. (1997) EMBO J. 16, 101-110
  18. Krems, B., Charizanis, C., and Entian, K.-D. (1995) Curr. Genet. 27, 427-434[Medline] [Order article via Infotrieve]
  19. Wu, A., and Moye-Rowley, W. S. (1994) Mol. Cell. Biol. 14, 5832-5839[Abstract]
  20. Grant, C. M., Collinson, L. P., Roe, J. H., and Dawes, I. W. (1996) Mol. Microbiol. 21, 171-179[Medline] [Order article via Infotrieve]
  21. Sikorski, R. S., and Hieter, P. (1989) Genetics 122, 19-27[Abstract/Free Full Text]
  22. Muller, E. G. D. (1991) J. Biol. Chem. 266, 9194-9202[Abstract/Free Full Text]
  23. Muller, E. G. D. (1994) J. Biol. Chem. 269, 24466-24471[Abstract/Free Full Text]
  24. Rose, M. D., Winston, F., and Hieter, P. (1990) Methods in Yeast Genetics, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
  25. Guthrie, C., and Fink, G. R. (1991) Methods Enzymol. 194, 273-362[Medline] [Order article via Infotrieve]
  26. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, 2nd Ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
  27. Brown, L. L., and Bussey, H. (1993) J. Bacteriol. 175, 6908-6915[Abstract]
  28. Baudin, A., Ozier-Kalogeropoulos, O., Danouel, A., Lacroute, F., and Cullin, C. (1993) Nucleic Acids Res. 21, 3329-3330[Medline] [Order article via Infotrieve]
  29. Liu, H., Krizek, J., and Bretscher, A. (1992) Genetics 132, 665-673[Abstract/Free Full Text]
  30. Schmitt, M. E., Brown, T. A., and Trumpower, B. L. (1990) Nucleic Acids Res. 18, 3091-3092[Medline] [Order article via Infotrieve]
  31. Gould, S. J., Keller, G.-A., and Subramani, S. (1988) J. Cell Biol. 107, 897-905[Abstract]
  32. Garrard, L. J., and Goodman, J. M. (1989) J. Biol. Chem. 264, 13929-13937[Abstract/Free Full Text]
  33. Goodman, J. M., Maher, J., Silver, P. A., Pacifico, A., and Sanders, D. (1986) J. Biol. Chem. 261, 3464-3468[Abstract/Free Full Text]
  34. Netto, L. E. S., Chae, H. Z., Kang, S.-W., Rhee, S. G., and Stadtman, E. R. (1996) J. Biol. Chem. 271, 15315-15321[Abstract/Free Full Text]
  35. Grant, C. M., MacIver, F. H., and Dawes, I. W. (1996) Curr. Genet. 29, 511-515[CrossRef][Medline] [Order article via Infotrieve]
  36. Shevshenko, A., Wilm, M., and Mann, M. (1996) Anal. Chem. 68, 850-858[CrossRef][Medline] [Order article via Infotrieve]
  37. Fernandes, L., Rodrigues-Pousada, C., and Struhl, K. (1997) Mol. Cell. Biol. 17, 6982-6993[Abstract]
  38. Stohs, S. J., and Bagchi, D. (1995) Free Radicals Biol. Med. 18, 321-336[CrossRef][Medline] [Order article via Infotrieve]
  39. Brennan, R. J., and Schiestl, R. H. (1996) Mutat. Res. 356, 171-178[CrossRef][Medline] [Order article via Infotrieve]
  40. Flohe, L. (1989) in Glutathione: Chemical, Biochemical and Medical Aspects (Dolphin, D., Poulson, R., and Avramovic, O., eds), pp. 643-722, John Wiley & Sons, New York
  41. Ursini, F., Maiorino, M., and Gregolin, C. (1985) Biochim. Biophys. Acta 839, 62-70[Medline] [Order article via Infotrieve]
  42. Brigelius-Flohe, R., Aumann, K. D., Bloker, H., Gross, G., Kiess, M., Kloppel, K. D., Maiorino, M., Roveri, A., Schuckelt, R., and Usani, F. (1994) J. Biol. Chem. 269, 7342-7348[Abstract/Free Full Text]
  43. Marinho, H. S., Antunes, F., and Pinto, R. E. (1997) Free Radicals Biol. Med. 22, 871-883[CrossRef][Medline] [Order article via Infotrieve]
  44. Mosialou, E., and Morgenstern, R. (1989) Arch. Biochem. Biophys. 275, 289-294[Medline] [Order article via Infotrieve]
  45. Hurst, R., Bao, Y., Jemth, P., Mannervick, B., and Williamson, G. (1998) Biochem. J. 332, 97-100[Medline] [Order article via Infotrieve]
  46. Bjornstedt, M., Hamberg, M., Kumar, S., Xue, J., and Holmgren, A. (1995) J. Biol. Chem. 270, 11761-11764[Abstract/Free Full Text]
  47. Altschul, S. F., Madden, T. L., Schaffer, A. A., Zhang, J., Zhang, Z., Miller, W., and Lipman, D. J. (1997) Nucleic Acids Res. 25, 3389-3402[Abstract/Free Full Text]
  48. Randez-Gil, F., Prieto, J. A., and Sanz, P. (1994) FEMS Microbiol. Lett. 122, 153-157[Medline] [Order article via Infotrieve]
  49. Hemmann, S., Blaser, K., and Crameri, R. (1997) Am. J. Respir. Crit. Care. Med. 156, 1956-1962[Abstract/Free Full Text]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.